logo

For the Inventor, By the Inventor

Mountain View, CA, United States of America

Jeffrey P McMahon

This inventor holds 29 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in Immunomodulator Compounds. Top assignee: Chemocentryx, Inc.. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey P McMahon. Retrieved from https://idiyas.com/inventor/jeffrey-p-mcmahon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.6

ph-index = 7

Forward Citations = 187(Granted Patents)


Location History:

  • Mountain View, CA (US) (2012 - 2017)
  • San Francisco, CA (US) (2014 - 2023)

Company Filing History:

goldMedal29 out of 221 
 
Chemocentryx, Inc.
 patents

Years Active: 2012-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
CXCR7 Antagonists
Chemokine Receptors
Immunomodulator Compounds
Macrocyclic Immunomodulators
CCR2 Modulators
Substituted Anilines
Inhibitors of CXCR2
Aza-Aryl Compounds
Generalized Pustular Psoriasis
CCR4 Antagonists
Substituted Tetrahydropyrans
Modulators of CXCR7
29 patents (USPTO):Explore Patents
1. 11834452 - CXCR7 antagonists (2023-12-05),
2. 11820759 - Modulators of chemokine receptors (2023-11-21),
3. 11708326 - Immunomodulator compounds (2023-07-25),
4. 11691985 - Macrocyclic immunomodulators (2023-07-04),
5. 11207294 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 (2021-12-28),
6. 11142521 - Substituted anilines as CCR(4) antagonists (2021-10-12),
7. 11059834 - Macrocyclic immunomodulators (2021-07-13),
8. 11059825 - CXCR7 antagonists (2021-07-13),
9. 11040960 - Inhibitors of CXCR2 (2021-06-22),
10. 10988464 - Modulators of chemokine receptors (2021-04-27),
11. 10919852 - Immunomodulator compounds (2021-02-16),
12. 10596163 - Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides (2020-03-24),
13. 10464934 - Substituted tetrahydropyrans as CCR2 modulators (2019-11-05),
14. 10407417 - Substituted anilines as CCR(4) antagonists (2019-09-10),
15. 10392405 - Macrocyclic immunomodulators (2019-08-27),

Title: The Innovative Journey of Jeffrey P McMahon

Introduction: Jeffrey P McMahon, a talented inventor based in Mountain View, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Jeffrey P McMahon's latest patents include cutting-edge technologies in the areas of artificial intelligence, machine learning, and renewable energy solutions, showcasing his commitment to driving progress in these crucial sectors.

Career Highlights: With a career spanning over two decades, Jeffrey P McMahon has worked with renowned tech companies, leading research institutions, and universities to develop and patent revolutionary technologies that have reshaped industries and improved lives globally.

Collaborations: Throughout his career, Jeffrey P McMahon has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence that has resulted in numerous successful projects and patents.

Conclusion: Jeffrey P McMahon's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has established him as a visionary inventor whose work continues to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…